| Deborah K Isaacson, MS/CCC-SLP | |
|
300 N 7th St, Bismarck, ND 58501-4439 | |
| (701) 323-6198 | |
| Not Available |
| Full Name | Deborah K Isaacson |
|---|---|
| Gender | Female |
| Speciality | Speech-language Pathologist |
| Location | 300 N 7th St, Bismarck, North Dakota |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1972796001 | NPI | - | NPPES |
| 50707 | Medicaid | ND |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 235Z00000X | Speech-language Pathologist | 546 (North Dakota) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Deborah K Isaacson, MS/CCC-SLP 300 N 7th St, Bismarck, ND 58501-4439 Ph: (701) 323-6198 | Deborah K Isaacson, MS/CCC-SLP 300 N 7th St, Bismarck, ND 58501-4439 Ph: (701) 323-6198 |
News Archive
Scientists from the Florida campus of The Scripps Research Institute (TSRI) have shown that a well-known cancer-causing gene implicated in a number of malignancies plays a far more critical role in non-small cell lung cancer, the most common form of the disease, than previously thought.
A new study found raised levels of transforming growth factor beta-induced protein (TGFBIp) in blood sampled from roughly 100 people hospitalized for COVID-19, and further found that elevated levels of both the normal and acetylated forms of TGFBIp correlated with the severity of disease symptoms in these patients.
Sosei Group Corporation confirms the information released today by Novartis that the European Commission has approved Seebri Breezhaler (glycopyrronium bromide) 44 mcg delivered dose (equivalent to 50 mcg glycopyrronium measured dose per capsule), as a once-daily inhaled maintenance bronchodilator treatment to relieve symptoms in adult patients with chronic obstructive pulmonary disease (COPD).
For the second time in less than one month, the University of Medicine and Dentistry of New Jersey-New Jersey Medical School has been awarded a coveted $15 million grant by the National Institutes of Health.
› Verified 3 days ago
Mrs. Kelli Katharina Ellenbaum, MS, CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 2625 N 19th St, Bismarck, ND 58503 Phone: 701-222-3175 Fax: 701-222-3186 | |
Sierra Larae Burgess, M.S. Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 210 S 12th St, Bismarck, ND 58504 Phone: 701-222-3175 Fax: 701-222-3186 | |
Rebecca Mcgillivray, Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 720 N 14th St, Bismarck, ND 58501 Phone: 701-323-4400 | |
Mrs. Karen Kaylene Davis, M. A. Speech-Language Pathologist Medicare: Medicare Enrolled Practice Location: 1600 E Interstate Ave Ste 3, Bismarck, ND 58503 Phone: 701-751-1125 Fax: 701-751-0729 | |
Linaya Ming, MS, CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 2625 N 19th St, Bismarck, ND 58503 Phone: 701-222-3175 Fax: 701-222-3186 | |
Donna Johnson, Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 806 N Washington St, Bismarck, ND 58501 Phone: 701-323-4028 Fax: 701-323-4027 | |
Kourtney Carr, M.S. SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 806 N Washington St, Bismarck, ND 58501 Phone: 701-323-4028 Fax: 701-323-4027 |